Chinese Health shareholder Ali Health plans to reduce its holdings by no more than 12 million shares; Orient shareholder Gongqingcheng Kunshun plans to reduce its holdings by no more than 3% in total; the shareholder and actual controller of Chuangshi Technology Holdings received a notice from the procuratorial authorities; Jinlong Mechatronics reported that it received a notice of filing; Hongxun Technology said that Italy's EEI did not directly produce and develop complete nuclear fusion machine devices; Tasley suspended clinical trials of amimumab
